CA1044164A - Glycoside hydrolase inhibiting amino sugar derivatives - Google Patents

Glycoside hydrolase inhibiting amino sugar derivatives

Info

Publication number
CA1044164A
CA1044164A CA209,484A CA209484A CA1044164A CA 1044164 A CA1044164 A CA 1044164A CA 209484 A CA209484 A CA 209484A CA 1044164 A CA1044164 A CA 1044164A
Authority
CA
Canada
Prior art keywords
alpha
compound
glucose
formula
amino sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA209,484A
Other languages
English (en)
French (fr)
Other versions
CA209484S (en
Inventor
Walter Puls
Delf Schmidt
Lutz Muller
Uwe Keup
Bodo Junge
Werner Frommer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA1044164A publication Critical patent/CA1044164A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA209,484A 1973-09-22 1974-09-18 Glycoside hydrolase inhibiting amino sugar derivatives Expired CA1044164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2347782A DE2347782C3 (de) 1973-09-22 1973-09-22 Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CA1044164A true CA1044164A (en) 1978-12-12

Family

ID=5893358

Family Applications (1)

Application Number Title Priority Date Filing Date
CA209,484A Expired CA1044164A (en) 1973-09-22 1974-09-18 Glycoside hydrolase inhibiting amino sugar derivatives

Country Status (28)

Country Link
JP (2) JPS5439474B2 (ja)
AR (1) AR210988A1 (ja)
AT (1) AT338199B (ja)
BE (1) BE820147A (ja)
BG (1) BG24959A3 (ja)
CA (1) CA1044164A (ja)
CH (1) CH596312A5 (ja)
CS (1) CS200173B2 (ja)
DD (1) DD117249A5 (ja)
DE (1) DE2347782C3 (ja)
DK (1) DK139979C (ja)
EG (1) EG12207A (ja)
ES (1) ES430283A1 (ja)
FI (1) FI56698C (ja)
FR (1) FR2244536B1 (ja)
GB (1) GB1482543A (ja)
HK (1) HK29780A (ja)
IE (1) IE39856B1 (ja)
IL (1) IL45685A (ja)
LU (2) LU88274I2 (ja)
NL (2) NL180941C (ja)
NO (1) NO142755C (ja)
PH (1) PH12530A (ja)
RO (1) RO84246B (ja)
SE (1) SE432111B (ja)
SU (1) SU562202A3 (ja)
YU (1) YU254574A (ja)
ZA (1) ZA745972B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel
US4175123A (en) * 1976-12-23 1979-11-20 Bayer Aktiengesellschaft Amino-sugar derivatives, process for their preparation and pharmaceutical composition thereof
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
DE3134591A1 (de) * 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
DE3543999A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
IT1293819B1 (it) * 1997-08-05 1999-03-10 Univ Massachusetts Lowell Procedimento per la preparazione di acarbosio
DE19844924A1 (de) * 1998-09-30 2000-04-06 Bayer Ag Immobilisierte Zellen von Actinoplanes acarbosefaciens SE 50/110, Immobilisierungsverfahren und Verwendung des Immobilisats zur Herstellung von Acarbose
US7022684B2 (en) 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
EP2145538A1 (de) 2008-07-15 2010-01-20 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Pflanzen- und Materialschutzmittel
TR201100150A2 (tr) 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Suda çözünür dozaj formları
TR201100148A2 (tr) 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Stabil akarboz förmülasyonları.
CN104144942A (zh) 2011-12-08 2014-11-12 拜耳知识产权有限责任公司 来自游动放线菌属菌种se50/110的新的放射菌整合和接合元件作为用于相关放线菌基因转化的质粒
WO2013115738A1 (en) 2012-01-31 2013-08-08 Mahmut Bilgic Micronized acarbose
EP2774619B1 (de) 2013-03-04 2016-05-18 BioActive Food GmbH Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
EP2944311A1 (de) 2014-05-16 2015-11-18 BioActive Food GmbH Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen

Also Published As

Publication number Publication date
PH12530A (en) 1979-05-17
LU70953A1 (ja) 1975-05-28
FI56698C (fi) 1980-03-10
ES430283A1 (es) 1976-12-16
EG12207A (en) 1979-03-31
DK497374A (ja) 1975-06-02
JPS5053593A (ja) 1975-05-12
IE39856L (en) 1975-03-22
AU7350374A (en) 1976-03-25
JPS5536479A (en) 1980-03-14
ATA757974A (de) 1976-12-15
DD117249A5 (ja) 1976-01-05
JPS5648518B2 (ja) 1981-11-16
HK29780A (en) 1980-06-06
FI274074A (ja) 1975-03-23
JPS5439474B2 (ja) 1979-11-28
DE2347782B2 (de) 1979-02-15
YU254574A (en) 1982-02-28
CS200173B2 (en) 1980-08-29
IE39856B1 (en) 1979-01-17
AR210988A1 (es) 1977-10-14
RO84246A (ro) 1984-05-23
ZA745972B (en) 1975-10-29
FR2244536B1 (ja) 1978-07-28
NL180941C (nl) 1987-05-18
NL930036I1 (nl) 1993-08-02
NL180941B (nl) 1986-12-16
BG24959A3 (en) 1978-06-15
FI56698B (fi) 1979-11-30
SE7411748L (ja) 1975-03-23
IL45685A0 (en) 1974-11-29
SU562202A3 (ru) 1977-06-15
SE432111B (sv) 1984-03-19
CH596312A5 (ja) 1978-03-15
NL930036I2 (nl) 1993-10-01
RO84246B (ro) 1984-07-30
NO142755B (no) 1980-06-30
GB1482543A (en) 1977-08-10
DK139979B (da) 1979-05-28
NL7412478A (nl) 1975-03-25
NO743210L (ja) 1975-04-21
LU88274I2 (ja) 1994-02-03
AT338199B (de) 1977-08-10
BE820147A (fr) 1975-03-20
DK139979C (da) 1979-10-29
NO142755C (no) 1980-10-08
IL45685A (en) 1979-05-31
DE2347782C3 (de) 1979-10-11
DE2347782A1 (de) 1975-04-10
FR2244536A1 (ja) 1975-04-18

Similar Documents

Publication Publication Date Title
CA1044164A (en) Glycoside hydrolase inhibiting amino sugar derivatives
US4062950A (en) Amino sugar derivatives
CA1121290A (en) Amino sugar derivatives
US4019960A (en) Process for the production of a saccharase inhibitor
US4316894A (en) Antibiotic SF-1130-x3 3 substance and production and use thereof
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
RU2134694C1 (ru) Аминоолигосахарид ск-4416, способ его получения, ингибитор сахаридгидролазы и антибактериальный агент
US4618602A (en) Amine containing pseudooligosaccharide, pharmaceutical composition and method of use
CH633043A5 (en) Process for preparing aminosugar derivatives
US4632917A (en) Pseudooligosaccharides with an α-glucosidase-inhibiting action, their use and pharmaceutical products
EP0560982A1 (en) Process for producing sugar and transfusion
US4990500A (en) Oxirane pseudooligosaccharides, a process for their preparation, their use and pharmaceutical preparations
KR790001709B1 (ko) 아미노-슈가 화합물의 제조방법
US3934006A (en) Pharmaceutical compositions comprising saccharase inhibitors
US4197292A (en) Novel amylase inhibitors
Pfeffer et al. Prefeeding-dependent anaerobic metabolization of xenobiotics by intestinal bacteria—methods for acarbose metabolites in an artificial colon
US6090610A (en) Macrolide compound 0406
FI63964C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara aminosockerderivat
PL91664B1 (ja)
IE44803B1 (en) Amino-sugar derivatives
US3995026A (en) Amylase inhibitor
JPH0647569B2 (ja) バリオ−ルアミン誘導体およびその製造法
JP3630378B2 (ja) ガラクトシルグリセロール類の製造方法
KR830001068B1 (ko) 아미노당 유도체의 제조방법
JPS58172400A (ja) 新規なアミノオリゴ糖誘導体